Latest Articles

Publication Date
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Cision News

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Cision News

Published: June 17, 2026, 7 a.m.
Placenta Accreta Spectrum Risk in Endometriosis: A Retrospective Cohort Study with ART Subanalysis.

Background/Objectives: This study assessed whether endometriosis is associated with an increased risk of placenta accreta spectrum (PAS) disorders and investigated if assisted reproductive technology (ART) further increases the risk in …

Published: June 17, 2026, midnight
Malignant transformation of uterine serosal endometriosis to clear cell carcinoma in a postmenopausal patient: a rare case report.

Endometriosis is a prevalent benign condition among women of reproductive age. While the overall rate of endometriosis-associated malignancy is low, the risk of malignant transformation increases significantly in postmenopausal patients, …

Published: June 17, 2026, midnight
Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis: Burden, Mechanism, and Implications for Treatment - EMJ

Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis: Burden, Mechanism, and Implications for Treatment EMJ

Published: June 16, 2026, 9:15 a.m.
POST-CESAREAN SCAR ENDOMETRIOSIS: LONG LATENCY, FREQUENT MISDIAGNOSIS, AND OUTCOMES OF SURGICAL EXCISION (A CASE SERIES OF 5 PATIENTS).

To analyze cesarean scar endometriosis as a long-term complication of cesarean section and to evaluate its clinical presentation, latency period, diagnostic features, and surgical outcomes.

Published: June 16, 2026, midnight
'Not Just Bad Periods': Survey of Aotearoa New Zealand Endometriosis Patients on Their Perspectives on the Impact of Endometriosis Awareness.

Endometriosis is a challenging condition to diagnose, frequently typified by long diagnostic delays. In an online survey study of 657 endometriosis patients from Aotearoa New Zealand, awareness of endometriosis at …

Published: June 16, 2026, midnight
Interleukin-17A as a key driver for cell migration, proliferation, inflammation, and nerve infiltration in deep endometriosis.

Deep endometriosis (DE) is the most severe subtype of endometriosis, marked by aggressive cellular behavior and debilitating pain. However, the molecular mechanisms underlying DE pathogenesis remain poorly understood. In this …

Published: June 15, 2026, midnight
Definitive diagnosis and surgical management of pleural and diaphragmatic endometriosis: a case report.

Thoracic endometriosis is an uncommon and frequently under recognized manifestation of endometriosis involving the pleura, diaphragm, or lung parenchyma. Patients often present with nonspecific cyclical thoracic or upper abdominal pain, …

Published: June 14, 2026, midnight
Lotus Endometriosis Institute Announces Resources For Diagnosis & Patient Advice - USA Today

Lotus Endometriosis Institute Announces Resources For Diagnosis & Patient Advice USA Today

Published: June 13, 2026, 7:32 p.m.
Ovarian Endometriosis and Adenomyosis-Relevance, Pathophysiology of Ectopic Endometrium and Impact on Dysfunction of Eutopic Endometrium: A Narrative Review.

A trend toward comorbid conditions is seen in around 50% of gynecological patients, with a significant contribution made by endometriosis as a common and incurable gynecological condition. Over the last …

Published: June 13, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!